by Esme Fowler-Mason | Dec 9, 2024 | Access to Care, NCD Policy, News
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
by Esme Fowler-Mason | Dec 9, 2024 | Access to Care, NCD Financing, News
Success in improving access to cancer care is not about a one-size-fits-all approach; it involves addressing unmet needs with high-impact actions. In its comprehensive white paper, Improving Access to Affordable and Sustainable Oncological Care in Africa, IQVIA...
by Esme Fowler-Mason | Nov 19, 2024 | Healthcare Systems, NCD Policy, News
“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
by Esme Fowler-Mason | Sep 9, 2024 | NCD Financing, NCD Policy, News
Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
by Esme Fowler-Mason | Feb 5, 2024 | Access to Care, NCD Partnerships, News
IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward addressing the challenges of...
